Matthew Butler

Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial

Jessica Ailani, Richard B. Lipton, Susan Hutchinson et al. · Headache The Journal of Head and Face Pain · 2020 · 101 citations · Full text

Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene‒related peptide‐targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug–drug interaction study

Abhijeet Jakate, Andrew Blumenfeld, Ramesh Boinpally et al. · Headache The Journal of Head and Face Pain · 2021 · 66 citations · Full text

Motion limitations of non-contact photoplethysmography due to the optical and topological properties of skin

Matthew Butler, John Crowe, Barrie Hayes‐Gill et al. · Physiological Measurement · 2016 · 46 citations · Full text

Topological Properties, Wearable System, Engineering +20

Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults

Peter J. Goadsby, Stewart J. Tepper, Paul B. Watkins et al. · Cephalalgia · 2019 · 46 citations · Full text

Single‐Dose Pharmacokinetics and Safety of Atogepant in Adults With Hepatic Impairment: Results From an Open‐Label, Phase 1 Trial

Ramesh Boinpally, Abhijeet Jakate, Matthew Butler et al. · Clinical Pharmacology in Drug Development · 2021 · 42 citations · Full text